6 patient evaluations for ALS Phase 3 Study Dexpramipexole (KNS-760704)
Sort by:
Most recent
Jan 16, 2013 (Started Aug 24, 2011)
-
EffectivenessCan't tell (for amyotrophic lateral sclerosis)
-
Side effectsNone (for Overall)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg
Daily
Cost:
< $25 monthly
Nov 26, 2012 (Started Aug 24, 2011)
-
EffectivenessMajor (for amyotrophic lateral sclerosis)
-
Side effectsNone (for Overall)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg
Daily
Advice & Tips:
Been rolled over to open-label for DEX. We hope to have a read-out soon (Dec/Jan) on results. I either have a really slow onset or this drug is really working... maybe both. While I've lost much strength in my right hand, all else is good for the last 2 years. My only negative was an early spike in Liver enzimines...
Cost:
< $25 monthly
- 0 helpful marks
Oct 10, 2012 (Started Sep 10, 2011)
-
EffectivenessCan't tell (for Participate in clinical trial)
-
EffectivenessCan't tell (for amyotrophic lateral sclerosis)
-
Side effectsNone (for Overall)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
2
Daily
- 0 helpful marks
Oct 11, 2012 (Started Jun 16, 2011)
-
EffectivenessCan't tell (for Participate in clinical trial)
-
Side effectsNone (for Overall)
-
AdherenceAlways
-
BurdenA little hard to take
Dosage:
300 mg
Daily
Advice & Tips:
This was a drug trial, I did'nt know if I had the placibo or the real drug. October 11,2012 the trial ended. They are giving me the real drug while they are analyzing the trial data.
- 0 helpful marks
Last updated:
Showing 3 of 6 patient evaluations for ALS Phase 3 Study Dexpramipexole (KNS-760704)